Crossmark

Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1016/j.aohep.2024.101534

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Stern, Louisa http://orcid.org/0000-0003-2296-9333
Schmidt, Constantin http://orcid.org/0000-0002-3892-4255
Kocheise, Lorenz

Joerg, Vincent

Casar, Christian http://orcid.org/0000-0002-8624-1045
Walter, Aurélie

Drenth, Joost P.H.

Papp, Maria

Gatselis, Nikolaos K.

Zachou, Kalliopi

Pinter, Matthias

Scheiner, Bernhard

Vogel, Arndt

Kirstein, Martha M.

Finkelmeier, Fabian

Waidmann, Oliver

Weinmann, Arndt http://orcid.org/0000-0003-1198-1716
Milkiewicz, Piotr

Thorburn, Douglas

Halliday, Neil

Lleo, Ana

Huber, Samuel http://orcid.org/0000-0001-9325-8227
Dalekos, George N.

Lohse, Ansgar W.

Wege, Henning

von Felden, Johann

Schulze, Kornelius
Funding

Funding for this research was provided by:

Bundesministerium für Bildung und Forschung (01EO2106)

Deutsche Forschungsgemeinschaft

Deutsche Krebshilfe

Wilhelm Sander-Stiftung
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-08-08
More Information

This article is maintained by: Elsevier

Article Title: Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2024.101534

Content Type: article

Copyright: © 2024 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.